261 related articles for article (PubMed ID: 26035688)
61. Lactoferrin in Aseptic and Septic Inflammation.
Lepanto MS; Rosa L; Paesano R; Valenti P; Cutone A
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987256
[TBL] [Abstract][Full Text] [Related]
62. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.
Naidu SAG; Wallace TC; Davies KJA; Naidu AS
J Diet Suppl; 2023; 20(2):218-253. PubMed ID: 33977807
[TBL] [Abstract][Full Text] [Related]
63. Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment.
Eker F; Bolat E; Pekdemir B; Duman H; Karav S
Front Aging Neurosci; 2023; 15():1204149. PubMed ID: 37731953
[TBL] [Abstract][Full Text] [Related]
64. Protective effects of recombinant lactoferrin with different iron saturations on enteritis injury in young mice.
Fan LL; Yao QQ; Wu HM; Wen F; Wang JQ; Li HY; Zheng N
J Dairy Sci; 2022 Jun; 105(6):4791-4803. PubMed ID: 35379462
[TBL] [Abstract][Full Text] [Related]
65. Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha.
Zakharova ET; Kostevich VA; Sokolov AV; Vasilyev VB
Biometals; 2012 Dec; 25(6):1247-59. PubMed ID: 23001680
[TBL] [Abstract][Full Text] [Related]
66. The antimicrobial activity of lactoferrin: current status and perspectives.
Orsi N
Biometals; 2004 Jun; 17(3):189-96. PubMed ID: 15222464
[TBL] [Abstract][Full Text] [Related]
67. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism.
Abrink M; Larsson E; Gobl A; Hellman L
Kidney Int; 2000 May; 57(5):2004-10. PubMed ID: 10792619
[TBL] [Abstract][Full Text] [Related]
68. Isolated rat hepatocytes differentially bind and internalize bovine lactoferrin N- and C-lobes.
Sitaram MP; McAbee DD
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):815-22. PubMed ID: 9169617
[TBL] [Abstract][Full Text] [Related]
69. Enhancement of blood-brain barrier penetration and the neuroprotective effect of resveratrol.
Katila N; Duwa R; Bhurtel S; Khanal S; Maharjan S; Jeong JH; Lee S; Choi DY; Yook S
J Control Release; 2022 Jun; 346():1-19. PubMed ID: 35398173
[TBL] [Abstract][Full Text] [Related]
70. Molecular cloning and functional expression of a human intestinal lactoferrin receptor.
Suzuki YA; Shin K; Lönnerdal B
Biochemistry; 2001 Dec; 40(51):15771-9. PubMed ID: 11747454
[TBL] [Abstract][Full Text] [Related]
71. Lactoferrin during lactation reduces lipopolysaccharide-induced brain injury.
Ginet V; van de Looij Y; Petrenko V; Toulotte A; Kiss J; Hüppi PS; Sizonenko SV
Biofactors; 2016 May; 42(3):323-36. PubMed ID: 27313089
[TBL] [Abstract][Full Text] [Related]
72. Lactoferrin structure and functions.
Legrand D; Pierce A; Elass E; Carpentier M; Mariller C; Mazurier J
Adv Exp Med Biol; 2008; 606():163-94. PubMed ID: 18183929
[TBL] [Abstract][Full Text] [Related]
73. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
Hartmann A; Mouatt-Prigent A; Vila M; Abbas N; Perier C; Faucheux BA; Vyas S; Hirsch EC
Neurobiol Dis; 2002 Jun; 10(1):28-32. PubMed ID: 12079401
[TBL] [Abstract][Full Text] [Related]
74. [Antitumor and chemopreventive activity of lactoferrin].
Artym J
Postepy Hig Med Dosw (Online); 2006; 60():352-69. PubMed ID: 16885906
[TBL] [Abstract][Full Text] [Related]
75. Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells.
Longhi C; Conte MP; Seganti L; Polidoro M; Alfsen A; Valenti P
Med Microbiol Immunol; 1993 Mar; 182(1):25-35. PubMed ID: 8497210
[TBL] [Abstract][Full Text] [Related]
76. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
Leveugle B; Faucheux BA; Bouras C; Nillesse N; Spik G; Hirsch EC; Agid Y; Hof PR
Acta Neuropathol; 1996; 91(6):566-72. PubMed ID: 8781654
[TBL] [Abstract][Full Text] [Related]
77. Piperazine derivatives as iron chelators: a potential application in neurobiology.
Abdelsayed S; Duong NT; Bureau C; Michel PP; Hirsch EC; Chahine JM; Serradji N
Biometals; 2015 Dec; 28(6):1043-61. PubMed ID: 26502356
[TBL] [Abstract][Full Text] [Related]
78. Physico-chemical properties of different forms of bovine lactoferrin.
Bokkhim H; Bansal N; Grøndahl L; Bhandari B
Food Chem; 2013 Dec; 141(3):3007-13. PubMed ID: 23871052
[TBL] [Abstract][Full Text] [Related]
79. Augmentation of human monocyte chemiluminescence by iron-saturated lactoferrin.
Ito M; Bognacki J; Broxmeyer H; DeSousa M; Hadden JW
Int J Immunopharmacol; 1983; 5(4):359-64. PubMed ID: 6629597
[TBL] [Abstract][Full Text] [Related]
80. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease.
An L; Sato H; Konishi Y; Walker DG; Beach TG; Rogers J; Tooyama I
Neurosci Lett; 2009 Mar; 452(3):277-80. PubMed ID: 19348738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
